Document is current
Any future updates will be listed below
-
Authors
Hauth, Antonia
Panten, Jasper
Kneuss, Emma https://orcid.org/0000-0003-0662-8539
Picard, Christel https://orcid.org/0000-0002-6135-596X
Servant, Nicolas https://orcid.org/0000-0003-1678-7410
Rall, Isabell
Pérez-Rico, Yuvia A. https://orcid.org/0000-0001-8436-0748
Clerquin, Lena
Servaas, Nila https://orcid.org/0000-0002-9825-7554
Villacorta, Laura
Jung, Ferris
Luong, Christy
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
Zaugg, Judith B. https://orcid.org/0000-0001-8324-4040
Stegle, Oliver https://orcid.org/0000-0002-8818-7193
Odom, Duncan T. https://orcid.org/0000-0001-6201-5599
Heard, Edith https://orcid.org/0000-0001-8052-7117
Loda, Agnese https://orcid.org/0000-0001-8109-128X
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 27 October 2025
First Online: 15 December 2025
Competing interests
: H.Y.C. is a cofounder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics; he was an advisor of 10x Genomics, Arsenal Biosciences, Chroma Medicine, Exai Bio and Spring Discovery until 15 December 2024. H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. The other authors declare no competing interests.
